The Biden administration believes that including obesity drugs in Medicare coverage will reduce out-of-pocket costs for the ...

With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...

A new Biden administration proposal could allow millions of Americans with obesity to access weight-loss drugs like Wegovy ...